These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23069581)

  • 21. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson's disease.
    Kim JI; Yang EJ; Lee MS; Kim YS; Huh Y; Cho IH; Kang S; Koh HK
    Int J Neurosci; 2011 Apr; 121(4):209-17. PubMed ID: 21265705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells.
    Bae JH; Jang BC; Suh SI; Ha E; Baik HH; Kim SS; Lee MY; Shin DH
    Neurosci Lett; 2006 May; 398(1-2):151-4. PubMed ID: 16417967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation.
    Zheng GM; Yu C; Yang Z
    Int J Oncol; 2012 May; 40(5):1610-8. PubMed ID: 22246431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
    J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
    Frau L; Borsini F; Wardas J; Khairnar AS; Schintu N; Morelli M
    Synapse; 2011 Mar; 65(3):181-8. PubMed ID: 20665698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretory-secretory products from Paragonimus westermani increase nitric oxide production in microglia in PKC-dependent and -independent manners.
    Jin Y; Choi IY; Kim C; Hong S; Kim WK
    Neurosci Res; 2009 Oct; 65(2):141-7. PubMed ID: 19539668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture.
    Katsuki H; Okawara M; Shibata H; Kume T; Akaike A
    J Neurochem; 2006 Jun; 97(5):1232-42. PubMed ID: 16638023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S; Moon M; Park S
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia.
    Cui YQ; Zhang LJ; Zhang T; Luo DZ; Jia YJ; Guo ZX; Zhang QB; Wang X; Wang XM
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):422-8. PubMed ID: 19843098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
    Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
    Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K; Inada T; Shingu K
    Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LPS-induced iNOS expression in N9 microglial cells is suppressed by geniposide via ERK, p38 and nuclear factor-κB signaling pathways.
    Zhang G; He JL; Xie XY; Yu C
    Int J Mol Med; 2012 Sep; 30(3):561-8. PubMed ID: 22710392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.
    Delgado M; Ganea D
    FASEB J; 2003 May; 17(8):944-6. PubMed ID: 12626429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells.
    Kong PJ; Lee HJ; Lee SH; Kim SY; Lee SN; Chun WJ; Kim SS
    Neurosci Lett; 2008 Mar; 433(3):215-8. PubMed ID: 18258363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
    Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
    Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.
    Rabaneda-Lombarte N; Serratosa J; Bové J; Vila M; Saura J; Solà C
    J Neuroinflammation; 2021 Apr; 18(1):88. PubMed ID: 33823877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease.
    Kokovay E; Cunningham LA
    Neurobiol Dis; 2005 Aug; 19(3):471-8. PubMed ID: 16023589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.